MedTrace Logo

The Effectiveness of "MaRiTensi" in Increasing Self-Care and Blood Pressure Control: Randomized Controlled Trial

NCT06049862 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2024-07-09

No results posted yet for this study

Summary

This study aims to know the effectiveness of "MaRiTensi" in improving knowledge, motivation, efficacy, self-care and blood pressure control for hypertension patients.

This study hypothesizes that MaRiTensi effectively increases the knowledge, motivation, self-efficacy and self-care of hypertensive patients and reduces blood pressure in the intervention group compared to the control group.

Respondent recruitment is as follows:

1. The respondent candidate will be identified based on data on record medical
2. Appropriate respondent candidates' criteria inclusion and exclusion contacted for given informed consent
3. Prospective respondents who are willing to participate and fulfill the criteria for pressure blood moment measurement will request signed consent
4. Respondents fill in the basic data and recapitulate by the assistant researcher
5. Done randomization for allocation of group interventions and group control
6. Respondents given envelope closed (using sequentially numbered, opaque sealed envelopes (SNOSE) method )
7. Respondents' group intervention was given maintenance by Hospital or health center standard-added intervention using MaRiTensi by conditions; meanwhile, group control was provided care by Hospital or health center standards.

Conditions

  • Primary Hypertension

Interventions

BEHAVIORAL

MaRiTensi App

MaRiTensi is a mobile health-based hypertension self-management application used on Android smartphones. MariTensi provides facilities for recording blood pressure, BMI, activity, examination results, education about hypertension, consultations, reminders and community chat.

Sponsors & Collaborators

  • Gadjah Mada University

    collaborator OTHER

  • Chatarina Setya Widyastuti

    lead OTHER

Principal Investigators

  • Chatarina S Widyastuti · Gadjah Mada University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-11
Primary Completion
2024-04-28
Completion
2024-04-28

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049862 on ClinicalTrials.gov